SteriPack has also implemented QAD at its facilities in Ireland, Poland and Malaysia.
SteriPack USA president Tony Paolino said QAD Enterprise Applications offer SteriPack USA business process continuity across all of facilities.
"Extending QAD to SteriPack USA enables us to rapidly onboard new operations that can run at peak performance to deliver consistent supply to our medical device customers," Paolino added.
QAD Enterprise Applications available in multiple languages with multi-tiered on-premise QAD On Demand software as a service (SaaS) and hybrid deployment options, offer end-to-end capabilities to improve business across a global enterprise.
The application supports quality requirements, including regulatory compliance, CAPA and Device History/Electronic Batch Record requirements and can be be validated to comply with Current Good Manufacturing Practices.
QAD also provides controls and audit capabilities along with eSignature support to meet compliance tracking.
Designed for single- or multi-site operations, QAD Enterprise Applications have different production models, plant locations and financial structures for global manufacturing companies in more than 90 countries, 27 languages and in multiple currencies.
QAD EMEA sales and marketing vice president Steve Gardner said, "Today’s manufacturing companies, like SteriPack, need enterprise solutions that provide the utmost agility for the rapidly shifting global marketplace."